STAT

A spot of good news in an Ebola crisis: Vaccine supplies are expected to last

There’s some good news related to an Ebola outbreak that has offered very little up till now.
Nurses working with the World Health Organization prepare to administer vaccines in Mbandaka in the Democratic Republic of the Congo. Source: UNIOR D. KANNAH/AFP/Getty Images

There’s some good news related to an Ebola crisis that has offered very little up until now. The World Health Organization now predicts there are adequate supplies of an experimental Ebola vaccine to control the outbreak in the Democratic Republic of the Congo.

“I believe we will have enough vaccine to stop this outbreak unless something very dramatic changes,” Dr. Peter Salama, WHO’s deputy director-general of emergency preparedness and response, told STAT.

And while an ongoing clinical trial of the vaccine may not be complete

You're reading a preview, sign up to read more.

More from STAT

STAT1 min read
STAT Plus: Pharmalittle: Gilead Faces Remdesivir Production Challenges; Will Scientists Run Out Of Covid-19 Trial Patients?
Gilead faces the challenge of scaling up production of remdesivir, its experimental #Covid19 drug that the whole world may want.
STAT1 min read
STAT Plus: Pharmalittle: U.S. Plans ‘Operation Warp Speed’ For A Covid-19 Vaccine; Gilead Vows Remdesivir Will Be Accessible
The Trump administration is organizing a Manhattan Project-style effort to drastically cut the time needed to develop a #coronavirus vaccine.
STAT1 min read
STAT Plus: Pharmalittle: Early Data Suggests Gilead Covid-19 Drug Works; Did FDA Drop Standards Too Far In Hunt For Chloroquine?
The U.S. government is pledging up to $483 million to accelerate the development of a Moderna experimental Covid-19 vaccine.